Cerevel soars on first data for muscarinic schizophrenia drugShares in Pfizer spinout Cerevel Therapeutics have more than doubled after it reported positive early-stage results with CVL-231, Share XCerevel soars on first data for muscarinic schizophrenia drughttps://pharmaphorum.com/news/cerevel-soars-on-first-data-for-muscarinic-schizophrenia-drug/
